Physician profile
Shawn Shah
NPI 1700415429
$9,856.38
in general payments reported to CMS, 2019-2025
14 companies · $2,336 in 2025
The $2,336 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $3,059 · 2023: $1,527 · 2024: $2,806 · 2025: $2,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,847 · Travel and Lodging: $1,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,847.13 |
| Travel and Lodging | $1,821.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,624.55 | 2021-2025 | Konect Resilia, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $2,134.02 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Bolton Medical INC | $785.34 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| Corcym INC | $663.32 | 2022-2025 | Perceval, Memo 4d |
| Dilon Technologies, INC. | $474.50 | 2023-2025 | Hemoblast Bellows |
| Stryker Corporation | $435.88 | 2022-2025 | Spy-Phi System, Na |
| Boston Scientific Corporation | $146.71 | 2022 | |
| Abbott Laboratories | $136.32 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Hemosonics LLC | $136.04 | 2023 | Quantra Qplus System |
| Zimmer Biomet Holdings, INC. | $123.73 | 2024 | Sternalock Blu System |
| Medtronic, INC. | $79.50 | 2022-2024 | Accuvac, Corevalve Evolut R |
| Ethicon US, LLC | $50.21 | 2024-2025 | Prolene, Ethicon |
| Nexus Medical Technologies LLC | $33.38 | 2025 | |
| Terumo Medical Corporation | $32.88 | 2025 | Glidesheath Slender, Tr Band, Navicross |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.